Metis Global Partners LLC Has $5.45 Million Stake in CME Group Inc. $CME

Metis Global Partners LLC reduced its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,767 shares of the financial services provider’s stock after selling 563 shares during the quarter. Metis Global Partners LLC’s holdings in CME Group were worth $5,448,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of CME. Jessup Wealth Management Inc lifted its holdings in CME Group by 0.5% during the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after buying an additional 36 shares in the last quarter. First Horizon Advisors Inc. raised its position in shares of CME Group by 0.7% during the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after acquiring an additional 36 shares during the last quarter. Great Lakes Advisors LLC lifted its stake in shares of CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after acquiring an additional 37 shares during the period. Beaumont Financial Advisors LLC boosted its holdings in CME Group by 2.0% in the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after acquiring an additional 38 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its position in CME Group by 0.8% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock worth $1,384,000 after purchasing an additional 38 shares during the period. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Rothschild & Co Redburn upped their target price on shares of CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research report on Thursday. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft raised shares of CME Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $266.00 to $300.00 in a research note on Thursday, October 23rd. Oppenheimer increased their price target on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Finally, TD Cowen raised their price target on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a research report on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $286.06.

View Our Latest Stock Analysis on CME Group

CME Group Trading Up 1.9%

CME opened at $276.50 on Friday. The firm’s fifty day moving average is $265.86 and its two-hundred day moving average is $272.34. The firm has a market cap of $99.71 billion, a PE ratio of 26.79, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. CME Group Inc. has a twelve month low of $222.56 and a twelve month high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s revenue was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.68 EPS. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio is presently 48.45%.

Insider Activity at CME Group

In other news, Director William R. Shepard bought 262 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The shares were acquired at an average price of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 14,043 shares of company stock valued at $3,791,486 over the last three months. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.